Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04475601
What this trial is testing

Enzalutamide Treatment in COVID-19

Who this might be right for
COVID-19Corona Virus Infection
Andreas Josefsson 42
Testing effectiveness (Phase 2)Study completedNCT05226767
What this trial is testing

Effect of Daily Oral Administration of Food Supplement NLC-V in Patients Diagnosed With COVID-19

Who this might be right for
COVID-19
Todos Medical, Ltd. 31
Not applicableStudy completedNCT05074953
What this trial is testing

Post-COVID-19 Monitoring in Routine Health Insurance Data

Who this might be right for
Virus DiseasesEpidemiology
Technische Universität Dresden 157,134
Testing effectiveness (Phase 2)Study completedNCT04339712
What this trial is testing

Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction

Who this might be right for
COVID-19Virus DiseasesMacrophage Activation Syndrome+1 more
Hellenic Institute for the Study of Sepsis 102
Post-approval studies (Phase 4)UnknownNCT05481177
What this trial is testing

Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort

Who this might be right for
Long Haul COVIDPostural Orthostatic Tachycardia Syndrome
Uniformed Services University of the Health Sciences 250
Not applicableUnknownNCT04381312
What this trial is testing

Direct and Indirect Impact of COVID-19 In Older Populations

Who this might be right for
Risk Factors for COVID-19 Outcomes in Elderly Populations
University Hospital, Grenoble 1,000
Not applicableNo Longer AvailableNCT04337359
What this trial is testing

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Who this might be right for
Severe/Very Severe COVID-19 Illness
Novartis Pharmaceuticals
Not applicableUnknownNCT06348186
What this trial is testing

Fascial Tissue Response to Manual Therapy: Implications in Long COVID-19

Who this might be right for
COVID-19
University of the State of Santa Catarina 30
Large-scale testing (Phase 3)Study completedNCT07079670
What this trial is testing

Safety and Immunogenicity of NVX-CoV2705

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sanofi 676
Early research (Phase 1)Study completedNCT05220605
What this trial is testing

Nebulised BromAc in Healthy Volunteers

Who this might be right for
COVID-19 PneumoniaBromelains Adverse ReactionAcetylcysteine Adverse Reaction+2 more
Mucpharm Pty Ltd 12
Not applicableStudy completedNCT04481620
What this trial is testing

Development and Validation of a Prediction Model for the Transition From Mild to Moderate Form of COVID-19, Using Data From Chest CT

Who this might be right for
COVID-19
University Hospital, Bordeaux 1,329
Early research (Phase 1)Study completedNCT05148754
What this trial is testing

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Who this might be right for
Covid19HIV-1-infection
Viriom 15
Not applicableUnknownNCT04786197
What this trial is testing

Detection of SARS-CoV-2 (COVID-19) by SERS Spectroscopy Combined With Artificial Intelligence

Who this might be right for
Covid19
Fondation Hôpital Saint-Joseph 712
Not applicableStudy completedNCT05338762
What this trial is testing

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

Who this might be right for
SARS-CoV2 Infection
MiCo BioMed Co., Ltd. 218
Not applicableStudy completedNCT05704803
What this trial is testing

COVID-19 Molecular OTC At Home Test

Who this might be right for
COVID-19 Pandemic
3EO Health 202
Not applicableStudy completedNCT05279469
What this trial is testing

D-Dimer as Predictor of Disease Outcome in Intensive Care Unit in COVID-19m Patients

Who this might be right for
Critical IllnessPneumonia, Viral
Ain Shams University 465
Large-scale testing (Phase 3)WithdrawnNCT04372082
What this trial is testing

Hydroxychloroquine or Diltiazem-Niclosamide for the Treatment of COVID-19

Who this might be right for
Sars-CoV2
University Hospital, Lille
Not applicableEnded earlyNCT04581070
What this trial is testing

The COVID-IYON Study - Study Examining Data Pertaining to Clinical Outcomes and Organisational Responses to the 2020 SARS-CoV-2 Pandemic"

Who this might be right for
CancerCOVID-19
Cancer Trials Ireland 4
Not applicableStudy completedNCT06806696
What this trial is testing

SARS-COV-2 VARIANTS' EFFECT ON PREGNANCY AND LONG-TERM OUTCOMES AMONG PREGNANT WOMEN AND THEIR NEWBORNS IN ESTONIA

Who this might be right for
PregnancyCOVID-19Post-COVID / Long-COVID+2 more
University of Tartu 60,739
Not applicableStudy completedNCT05060562
What this trial is testing

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population

Who this might be right for
Covid19
Hasanuddin University 6,051
Next Page